Iviva Medical

BEVERLY, MA · Founded 2013 · CIK 0001732139 · Biotech · Acquired

Fully transplantable bioartificial kidneys combining biological and synthetic components

ivivamedical.com →
Grants
$100K
1 award
Sector median: 1
Raised
$2.0M
1 Form D · Mar 2018
102 months since last filing
Contracts
—
No federal contracts on record
Patents
22
5 granted · 17 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Defense · Phase I · Platform to Generate Advanced Filtration Function in Renal Tissue Scaffolds: A Hemodialysis Graft as Proof of Concept$99,802
Private capital raisedForm D · SEC$2,050,000
Federal grant · SBIR/STTRForm D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1941Myota, Inc.—$16M
1942AXIOMX INC——
1943Sparrow Pharmaceuticals—$73M
1944Iviva Medical—$2.0M
1945PanTheryx, Inc.—$84M
1946Vero Biotech Inc.—$84M
1947RAKTA THERAPEUTICS, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 2 related persons
  • Harald OttDirector
  • Brock ReeveExecutive Officer

Patents

USPTO · 5 granted of 22

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.